NVZMY News and Press, Novozymes A/S ADR From 02/26/25

2025-02-26 03:05:08 ET More on Novonesis A/S, Novonesis A/S, etc. Novonesis: Still Too Expensive Historical earnings data for Novonesis A/S Financial information for Novonesis A/S Seeking Alpha’s Quant Rating on Novonesis A/S Historical earning...

Airbus SE ADR - Level I (EADSY) is expected to report $0.66 for Q4 2024 Prelude Therapeutics Incorporated (PRLD) is expected to report $-0.49 for Q4 2024 Boise Cascade L.L.C. (BCC) is expected to report $1.82 for Q4 2024 CN Energy Group Inc. (CNEY) is expected to report for quarter en...

2025-02-16 21:25:00 ET Summary The MSCI World Net Index climbed 18.7% for the year, marking its second consecutive annual gain above 15%, and capping a remarkable two-year run with a 47% total return. Mar Vista’s Global Quality strategy returned -3.31% net-of-fees in the fo...

West Pharmaceutical Services Inc. (WST) is expected to report $1.75 for Q4 2024 Vanda Pharmaceuticals Inc. (VNDA) is expected to report $-0.14 for Q4 2024 Cineverse Corp. (CNVS) is expected to report for Q3 2025 British American Tobacco p.l.c. (BTI) is expected to report for Q4 2024 ...

2025-02-07 05:32:40 ET Summary Givaudan's fiscal year 2024 results were strong, with 12.3% like-for-like sales growth and a 22.1% increase in net income, despite currency headwinds. The company maintains a robust competitive moat through heavy R&D investment, a strong patent p...

First National Corporation (FXNC) is expected to report $0.47 for Q4 2024 Insight Enterprises Inc. (NSIT) is expected to report $2.53 for Q4 2024 Phillips Edison & Company Inc. (PECO) is expected to report $0.61 for Q4 2024 Lumentum Holdings Inc. (LITE) is expected to report $-0.0...

2025-02-06 00:20:58 ET Summary Novonesis, formed from Novozymes and Christian Hansen, is a strong business with stable margins and high ROIC, but recent growth rates have declined. Despite solid Q3/24 results, NVZMF's long-term growth has slowed, though management and analysts exp...

LEG Immobilien SE Registered Shares (LEGIF) is expected to report for Q3 2024 CURO Group Holdings Corp. (CUROQ) is expected to report for Q3 2024 Lifecore Biomedical Inc. (LFCR) is expected to report $-0.27 for Q2 2025 Flux Power Holdings, Inc. (FLUX) is expected to report $-0.12 for ...